Contact
searchSearch
HMP Global

Venous Disease: Features

Dr Xhorlina Marko
ISET 2025
An Update on the Data and Devices for the Treatment of DVT
03/21/2025
Iinterventional radiologist Xhorlina Marko, MD, from Henry Ford Health in Detroit, Michigan, discusses the details of her ISET 2025 presentation on the latest data and devices for DVT treatment.
Iinterventional radiologist Xhorlina Marko, MD, from Henry Ford Health in Detroit, Michigan, discusses the details of her ISET 2025 presentation on the latest data and devices for DVT treatment.
Iinterventional radiologist...
03/21/2025
Vascular Disease Management
Interview
STRIKE-PE: Interim Analysis of the First 300 Patients Using Lightning Flash
03/05/2025
Brian J. Schiro, MD
VDM spoke with Dr Schiro about STRIKE-PE, a study that evaluated the efficacy and long-term safety outcomes of treating PE with Lightning Flash (Penumbra).
VDM spoke with Dr Schiro about STRIKE-PE, a study that evaluated the efficacy and long-term safety outcomes of treating PE with Lightning Flash (Penumbra).
VDM spoke with Dr Schiro about...
03/05/2025
Vascular Disease Management
Interview
The PEERLESS Trial: What Are the Implications for the Management of Pulmonary Embolism?
02/26/2025
Ripal T. Gandhi, MD, FSIR, FSVM
Ripal Gandhi, MD, speaks with Vascular Disease Management about his presentation at ISET 2025 on the PEERLESS trial.
Ripal Gandhi, MD, speaks with Vascular Disease Management about his presentation at ISET 2025 on the PEERLESS trial.
Ripal Gandhi, MD, speaks with...
02/26/2025
Vascular Disease Management
Dr Harnain
ISET 2025
Case Studies & Discussion: Venous Compression Syndromes
02/02/2025
Read about Dr Christopher M. Harnain's ISET 2025 presentation on venous compression syndromes.
Read about Dr Christopher M. Harnain's ISET 2025 presentation on venous compression syndromes.
Read about Dr Christopher M....
02/02/2025
Vascular Disease Management
Dr Jaffer
LINC 2025
Creating EndoAVF: New Evidence and Upcoming Trials
01/30/2025
Ounali Jaffer, MD, walked through his experience in using endoAVF and touched on the past, present, and future insights that may potentially drive this field. 
Ounali Jaffer, MD, walked through his experience in using endoAVF and touched on the past, present, and future insights that may potentially drive this field. 
Ounali Jaffer, MD, walked...
01/30/2025
Vascular Disease Management
Dr Hirsch
LINC 2025
Odds and Limitations of Duplex Sonography in the Diagnosis of PeVD
01/28/2025
Tobias Hirsch, MD
Dr Tobias Hirsch discusses his LINC 2025 presentation on diagnosing pelvic venous disorders with duplex sonography.
Dr Tobias Hirsch discusses his LINC 2025 presentation on diagnosing pelvic venous disorders with duplex sonography.
Dr Tobias Hirsch discusses his...
01/28/2025
Vascular Disease Management
Original Research
Impact of Deep Venous Stenting on Healing Rates of Venous Leg Ulcers
01/23/2025
Antonio Solano, MD; Andrea Klein, MD; Gerardo Gonzalez-Guardiola, MD; Khalil Chamseddin, MD; Michael Shih, MD; Vivek Prakash, MD; Shadman Baig, MD; Carlos H Timaran, MD; Melissa L Kirkwood, MD; Michael Siah, MD
Venous leg ulcers (VLUs) have a significant symptomatic and quality-of-life burden for patients with CVI despite medical treatment and wound care. This study reports the impact of deep venous stenting in patients with chronic VLUs.
Venous leg ulcers (VLUs) have a significant symptomatic and quality-of-life burden for patients with CVI despite medical treatment and wound care. This study reports the impact of deep venous stenting in patients with chronic VLUs.
Venous leg ulcers (VLUs) have a...
01/23/2025
Vascular Disease Management
Interview
Using Artificial Intelligence to Diagnose Pulmonary Embolism
01/15/2025
Patrick Muck, MD
Dr Patrick Muck discusses how AI enhances the speed and accuracy of a PE diagnosis and what the future may hold for AI to diagnose other vascular diseases.
Dr Patrick Muck discusses how AI enhances the speed and accuracy of a PE diagnosis and what the future may hold for AI to diagnose other vascular diseases.
Dr Patrick Muck discusses how AI...
01/15/2025
Vascular Disease Management
Interview
The American Vein and Lymphatic Society Position Statement on Mechanical Occlusion Chemically Assisted Ablation of Varicose Veins for Venous Insufficiency
12/01/2024
John Blebea, MD, MBA
John Blebea, MD, MBA, from the Central Michigan University College of Medicine in Saginaw, Michigan, discusses latest position statement of the AVLS on mechanical occlusion chemically assisted ablation.
John Blebea, MD, MBA, from the Central Michigan University College of Medicine in Saginaw, Michigan, discusses latest position statement of the AVLS on mechanical occlusion chemically assisted ablation.
John Blebea, MD, MBA, from the...
12/01/2024
Vascular Disease Management
Interview
New Tools for Eliminating Venous Obstruction and Valvular Reflux
06/27/2024
At the 2024 SIR Meeting, interventional radiologist Kush Desai, MD, presented several sessions, including one on this topic. VDM spoke with Dr. Desai about his presentation and the latest thrombectomy devices.
At the 2024 SIR Meeting, interventional radiologist Kush Desai, MD, presented several sessions, including one on this topic. VDM spoke with Dr. Desai about his presentation and the latest thrombectomy devices.
At the 2024 SIR Meeting,...
06/27/2024
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

VentiV Clinical Images
Thrombectomy
FDA Clears New Mechanical Thrombectomy System
03/31/2025
VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform.
VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform.
VentiV Scientific announced the...
03/31/2025
Cath Lab Digest
Restenosis
Real-world Data Shows Cook’s Zilver PTX Leads to Lower Rates of In-stent Occlusion Than Boston Scientific’s Eluvia
03/27/2025
Bloomington, Ind. — Cook Medical’s Zilver PTX drug-eluting stent (DES) has lower rates of in-stent occlusions among patients with restenosis at 3 years than Boston Scientific’s Eluvia DES, according to real-world data from the REALDES study....
Bloomington, Ind. — Cook Medical’s Zilver PTX drug-eluting stent (DES) has lower rates of in-stent occlusions among patients with restenosis at 3 years than Boston Scientific’s Eluvia DES, according to real-world data from the REALDES study....
Bloomington, Ind. — Cook...
03/27/2025
Vascular Disease Management
TAVR
Medtronic’s Evolut Trial Outcome Could Shake Up US TAVR Market, Says GlobalData
03/21/2025
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results...
03/21/2025
Vascular Disease Management
Embolotherapy
Instylla Completes Submission of Premarket Approval Application for Embrace™ Hydrogel Embolic System
03/11/2025
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025...
03/11/2025
Vascular Disease Management
Resistant Hypertension
Corcept Therapeutics Initiates MOMENTUM Trial to Determine Prevalence of Hypercortisolism in Patients with Resistant Hypertension
03/10/2025
“Resistant hypertension is a serious public health challenge. Patients whose hypertension remains in poor control despite receiving optimal care, including multiple medications, are at greater risk of cardiovascular morbidity and mortality,”...
“Resistant hypertension is a serious public health challenge. Patients whose hypertension remains in poor control despite receiving optimal care, including multiple medications, are at greater risk of cardiovascular morbidity and mortality,”...
“Resistant hypertension is a...
03/10/2025
Cath Lab Digest
Company expansion
Reflow Medical Expands Global Reach With New European Subsidiary
03/06/2025
Reflow Medical, Inc., a developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary in Landsberg am Lech, Germany.
Reflow Medical, Inc., a developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary in Landsberg am Lech, Germany.
Reflow Medical, Inc., a...
03/06/2025
Cath Lab Digest
SCAI
Survey Confirms Radiation and Orthopedic Health Hazards in Cardiac Catheterization Laboratories are ‘Unacceptable’
03/05/2025
A survey conducted by the Society for Cardiovascular Angiography and Interventions (SCAI) highlights ongoing radiation and orthopedic hazards faced by interventional cardiologists and cardiac catheterization laboratory (“cath lab” or CCL)...
A survey conducted by the Society for Cardiovascular Angiography and Interventions (SCAI) highlights ongoing radiation and orthopedic hazards faced by interventional cardiologists and cardiac catheterization laboratory (“cath lab” or CCL)...
A survey conducted by the...
03/05/2025
Cath Lab Digest
Shockwave Javelin Peripheral IVL Catheter, a novel intravascular lithotripsy (IVL) platform designed to modify calcium and cross extremely narrowed vessels in patients with peripheral artery disease (PAD).
IVL
Shockwave Medical Launches Novel Forward Intravascular Lithotripsy Platform in U.S. to Transform Treatment of Difficult-to-Cross Calcified Lesions
03/04/2025
Now available in the U.S., the Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter safely modifies and crosses occlusive or extremely narrowed calcific peripheral artery disease.
Now available in the U.S., the Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter safely modifies and crosses occlusive or extremely narrowed calcific peripheral artery disease.
Now available in the U.S., the...
03/04/2025
Cath Lab Digest
Acute Ischemic Stroke
FDA Approves Genentech’s TNKase® in Acute Ischemic Stroke in Adults
03/03/2025
Genentech announced that the U.S. FDA has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Genentech announced that the U.S. FDA has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Genentech announced that the...
03/03/2025
Vascular Disease Management
TEVAR
Zenith Alpha Thoracic 2 Now Available in US; First Case Performed
03/03/2025
Cook Medical’s Zenith Alpha® 2 Thoracic Endovascular Graft (ZTA2) is now commercially available throughout the United States.
Cook Medical’s Zenith Alpha® 2 Thoracic Endovascular Graft (ZTA2) is now commercially available throughout the United States.
Cook Medical’s Zenith Alpha® 2...
03/03/2025
Vascular Disease Management

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use